CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Placebo pill +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01817907
NCT01817907N/ACompleted

The Effects of Trazodone on the Severity of Obstructive Sleep Apnea

Brigham and Women's Hospital·interventional·Posted Mar 26, 2013·Updated Feb 24, 2017

In Brief

A clinical study evaluating Placebo pill and Trazodone for Sleep Apnea, Obstructive. Completed, enrolled 15 participants across 1 site.

Detailed Summary

In Obstructive sleep apnea (OSA), the upper airway closes over and over again during sleep. This leads to disrupted sleep (waking up during the night), daytime sleepiness, and an increased risk for developing high blood pressure. Currently, the best treatment for obstructive sleep apnea is sleeping with a mask that continuously blows air into the nose (i.e. Continuous positive airway pressure \[CPAP\] treatment). While CPAP treatment stops the upper airway from closing in most people, many people have difficulty sleeping with the mask in place and therefore do not use the CPAP treatment. This research study is being conducted to learn whether using a sedative will improve OSA severity by altering some of the traits that are responsible for the disorder.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMar 26, 2013
Enrollment StartMar 1, 2013
Primary CompletionApr 1, 2014
Study CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 13.3 years ago

Interventions

Placebo pilldrug

Subjects will receive a sugar pill during the placebo arm

Trazodonedrug

Subjects will receive trazodone during one of their treatment arm studies